ArticleProtein science : a publication of the Protein Society2026
Covalent drug rescue of multiple p53 mutants by stabilizing vinyl sulfone fragments hints to a specific refolding mechanism for R282W.
Article in Protein science : a publication of the Protein Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Covalent drug rescue of multiple p53 mutants by stabilizing vinyl sulfone fragments hints to a specific refolding mechanism for R282W.Protein science : a publication of the Protein Society · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
The tumor suppressor protein p53 plays a crucial role in cell cycle regulation. In approximately 50% of all tumors, mutations in p53 are observed. Although the top hot spot mutations impair DNA binding, other mutations affect the thermal stability of the protein, leading to its rapid denaturation in physiological conditions. Previously, we have identified VS004, a vinyl sulfone containing fragment that stabilized p53C-WT by about 5°C. In this study, we screened the CovLib fragments VS002, VS003, VS004, and two VS004 analogs against wild-type p53C, as well as the mutants R273H, Y220C, and R282W. VS004 and its analogs demonstrated stabilizing effects on all tested p53 variants, with the strongest effect (almost 6°C) on R282W. We solved the crystal structures of VS004-2 bound to Y220C and R282W. In the Y220C crystal structure, VS004-2 bound to C277 and stabilized the loop L1. For R282W, we observed binding to C275, which leads to an unexpected structural reorganization of the C-terminal helix H2. Although the arylated cysteines are both near the DNA-binding interface, fluorescence polarization experiments using five different response elements confirm that DNA binding appears not to be compromised. The compounds present an interesting starting point for both general and mutant specific p53 stabilization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.